Baxter International Stock Hits Day Low of $16.08 Amid Price Pressure

Baxter International, Inc. experienced significant volatility on March 20, 2026, with the stock hitting an intraday low of USD 16.08. The company, operating in the Pharmaceuticals & Biotechnology sector, saw its stock decline by 8.34% for the day, contrasting sharply with the S&P 500's performance, which fell by only 1.51%. Over the past week, Baxter's stock has dropped 10.53%, and its one-month performance shows a decline of 26.15%. The year-to-date performance reflects a decrease of 15.49%, while the stock has faced a staggering 53.2% decline over the past year. Long-term trends indicate a troubling trajectory, with a 57.03% drop over the last three years and a significant 79.78% decline over the past five and ten years. Financial metrics reveal challenges, including a high Debt to EBITDA ratio of 3.86 times and a negative trend in operating profits, which have seen a compound annual growth rate (CAGR) of -17.50% over the last five years. Additionally, the company has reported negative results for three consecutive quarters, with net sales falling by 26.29% and pre-tax profits down by 45.07%.